Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 ‘CREATE’
Schöffski, P, Wozniak, A, Stacchiotti, S, Rutkowski, P, Blay, J-Y, Lindner, L H, Strauss, S J, Anthoney, A, Duffaud, F, Richter, S, Grünwald, V, Leahy, M G, Reichardt, P, Sufliarsky, J, van der Graaf,Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx823
Date:
May, 2018
File:
PDF, 41 KB
english, 2018
File converter
More search results
More benefits 
